DEVA:IST
Deva Holding AS
85,85 TRY
arrow_downward
-1,32%(-1,15) 1 d
9 oct, 18:10:00 GMT+3 · TRY
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de DEVA...
Abrir
87,35 TRY
Alto
88,30 TRY
Bajo
85,15 TRY
Cap. burs.
17,17 mil M
Vol. medio
673,14 mil
Volumen
241,60 mil
Máximo en 52 sem.
109,30 TRY
Mínimo en 52 sem.
57,50 TRY
BPA
-4,21 TRY
Acciones en circulación
200,02 M
N.º de empleados
3 mil
Abrir
87,35 TRY
Alto
88,30 TRY
Bajo
85,15 TRY
Cap. burs.
17,17 mil M
Vol. medio
673,14 mil
Volumen
241,60 mil
Máximo en 52 sem.
109,30 TRY
Mínimo en 52 sem.
57,50 TRY
BPA
-4,21 TRY
Acciones en circulación
200,02 M
N.º de empleados
3 mil
Noticias
De fuentes web y partners de noticias
Negocios.com
·
hace 43 minutos
Balance de la semana: el Dow Jones gana casi 500 puntos y apunta a los 52.000
Negocios.com
·
hace 1 hora
El Dow Jones gana 423 puntos tras el acuerdo sorpresa entre Trump y Putin
El Ecosistema Startup
·
hace 15 horas
S&P 500 rebota: ingresos de OpenAI y baja del petróleo
TradingView
·
hace 9 horas
Dow sube 423 puntos; tecnológicas repuntan y telecos caen por SpaceX
Perfil
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
Acerca de Deva Holding AS